Treatment
Roflumilast 0.3% topical foam clinical trials
We’re tracking 3 recruiting studies that include Roflumilast 0.3% topical foam, each written for real people, not researchers, below.
Recruiting studies
- NCT07105254RecruitingPhase 2
Roflumilast foam study for children with vitiligo
This study tests a medicated foam (Roflumilast) in children with non-segmental vitiligo to see if it can improve skin color on the face and body. It is for patients aged 2 to 17 with small patches and at least some pigmented hair in the face patches.
Dallas, TexasAges 2–18 - NCT07263230RecruitingPhase 2
Roflumilast Foam for Hidradenitis Suppurativa
This study tests whether roflumilast foam (a prescription foam) is safe and can reduce inflamed bumps in people with mild-to-moderate hidradenitis suppurativa (HS) who do not have draining tunnels. Participants will stop other HS treatments during the trial.
Boston, MassachusettsAges 18 years+ - NCT07077902RecruitingPhase 2
Roflumilast foam for hidradenitis suppurativa
This study tests if a foam applied to the skin (roflumilast 0.3%) is safe and effective for treating hidradenitis suppurativa (HS). It may help people with mild to moderate HS who haven't had success with other treatments.
Covington, LouisianaAges 18–90
What Roflumilast 0.3% topical foam is being studied for
Conditions with recruiting Roflumilast 0.3% topical foam studies.
Common questions
- Are there clinical trials studying Roflumilast 0.3% topical foam?
- Yes. Clin2 currently lists 3 recruiting studies that include Roflumilast 0.3% topical foam, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Roflumilast 0.3% topical foam trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Roflumilast 0.3% topical foam an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Roflumilast 0.3% topical foam or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.